SUBASH NEPAL

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease PIKEVILLE, KY NPI 1740701580

General Payments — all program years on this page

$730.87

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 44
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $614.83 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $614.8338

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $116.046
2024 $614.8338

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080704006 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $23.88 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080704008 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $15.36 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121528 Novartis Pharmaceuticals Corporation $3.07 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121532 Novartis Pharmaceuticals Corporation $19.45 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121534 Novartis Pharmaceuticals Corporation $17.86 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121536 Novartis Pharmaceuticals Corporation $5.35 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121538 Novartis Pharmaceuticals Corporation $6.39 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121540 Novartis Pharmaceuticals Corporation $1.33 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121542 Novartis Pharmaceuticals Corporation $22.53 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121544 Novartis Pharmaceuticals Corporation $11.31 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121546 Novartis Pharmaceuticals Corporation $18.47 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121548 Novartis Pharmaceuticals Corporation $0.34 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121550 Novartis Pharmaceuticals Corporation $4.33 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121552 Novartis Pharmaceuticals Corporation $0.17 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121554 Novartis Pharmaceuticals Corporation $8.05 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121556 Novartis Pharmaceuticals Corporation $16.60 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121558 Novartis Pharmaceuticals Corporation $17.37 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121560 Novartis Pharmaceuticals Corporation $1.46 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121562 Novartis Pharmaceuticals Corporation $29.35 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121564 Novartis Pharmaceuticals Corporation $9.95 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121566 Novartis Pharmaceuticals Corporation $8.34 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087121568 Novartis Pharmaceuticals Corporation $4.20 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092487362 Boston Scientific Corporation $9.55 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092487364 Boston Scientific Corporation $10.56 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092487366 Boston Scientific Corporation $11.14 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092487368 Boston Scientific Corporation $11.21 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092487370 Boston Scientific Corporation $12.25 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092487372 Boston Scientific Corporation $136.49 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101663611 E.R. Squibb & Sons, L.L.C. $14.95 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104224563 AstraZeneca Pharmaceuticals LP $18.24 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125236151 Abbott Laboratories $24.91 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125236154 Abbott Laboratories $25.74 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130875944 PFIZER INC. $13.65 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130958404 PFIZER INC. $15.41 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131494853 PFIZER INC. $17.15 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131859333 PFIZER INC. $14.13 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132901570 ATRICURE, INC. $14.54 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154168382 HEARTFLOW, INC. $19.75 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.